189,00 €
The antibody test for type 1 diabetes analyses the presence of several autoantibodies together, rather than in isolation, giving a more reliable picture of the risk of disease progression. Detecting them before symptoms appear gives a more accurate picture of autoimmunity.
79,99 € — or subscribe to save up to 20%
With this home analysis you can control your lipid profile and prevent the development of diseases, with results interpreted by a doctor. Especially suitable for people with risk factors, family history or who wish to actively take care of their heart.
74,99 € — or subscribe to save up to 20%
With this test you can measure the key biomarkers for diabetes management: HbA1c, creatinine and glomerular filtration rate. You can monitor your treatment or detect diabetes if you have risk factors such as family history or overweight (without being a definitive test). Results and medical interpretation included.
54,99 €
Total PSA is a parameter used to detect prostate disorders, including cancer. A PSA test is recommended from the age of 45, or earlier if there is a family history of prostate cancer. Knowing your levels is a first step towards early detection.
69,00 €
Normal cholesterol but history of heart attack? Lipoprotein(a) is a genetic marker of cardiovascular risk that is not included in routine testing. Elevated levels can increase cardiac risk even with normal cholesterol. International guidelines recommend testing for Lp(a) at least once in a lifetime to anticipate and make informed decisions.
Neutral and confidential package with everything you need
Delivery of the kit in 24-48 hours in the peninsula.
Samples analysed by certified laboratories
Data protected to the highest security standards
You receive the kit in 24-48h, take the sample in 5 min, programme collection and receive results with medical interpretation.
Yes, we work with CAP and ISO 15189 accredited laboratories following the standards in clinical health procedures.
No. You can take any test without a prescription or appointment.
.
